Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
Szczepan is a scientist and veterinarian turned “technology geek.” He is passionate about transforming the delivery of innovative medicines to patients through digital technologies and data enablement while pushing the scientific envelope and reimagining patient engagement. Szczepan currently serves as a Chief Scientific Officer at VeriSIM Life where he leads the research and development strategy and oversees scientific functions, including basic and applied research projects, and develops new processes, technologies, and products.
He previously served as a Head of Emerging Technologies within Comparative Medicine at Novartis. In this position, he led an integrated digital enterprise strategy focusing on developing and incorporating patient-relevant AI technologies and conducted decentralized clinical trials (DCT). In parallel, Szczepan focused on stakeholder engagement to identify adaptation hurdles and develop a regulatory qualification pathway for Microphysiological Systems (MPS) technologies. He has played instrumental roles in establishing Global MPS and Digital Biomarkers Groups with a vision for strategic alignment and data agility.
Szczepan is a graduate of the University of Delaware and the University of Pennsylvania School of Veterinary Medicine. He completed his residency in Laboratory Animal Medicine and received a Master of Science degree in Comparative Medicine from the University of Washington.
Before joining VeriSIM Life, Szczepan held multiple start-up and faculty positions and served on numerous boards. He chaired the IQ MPS Affiliate and led the IQ MPS Affiliate Regulatory Outreach Group. Currently, he serves as an advisory board member at BRIDGE, ad hoc member of National Academies on the NHP Model Systems Committee, a co-chair of the MPS and Translational Digital Biomarker Initiatives of the North American 3Rs Collaborative, and serves on the Scientific Advisory Committee on Alternative Toxicological Methods (SACATM) ad hoc member.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.